John V. Burba

464 total citations
12 papers, 357 citations indexed

About

John V. Burba is a scholar working on Molecular Biology, Pharmacology and Physical and Theoretical Chemistry. According to data from OpenAlex, John V. Burba has authored 12 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Physical and Theoretical Chemistry. Recurrent topics in John V. Burba's work include Pharmacogenetics and Drug Metabolism (2 papers), Analytical Methods in Pharmaceuticals (2 papers) and Cancer therapeutics and mechanisms (1 paper). John V. Burba is often cited by papers focused on Pharmacogenetics and Drug Metabolism (2 papers), Analytical Methods in Pharmaceuticals (2 papers) and Cancer therapeutics and mechanisms (1 paper). John V. Burba collaborates with scholars based in Canada. John V. Burba's co-authors include B. Belleau, Marie Fang and Joseph Moran and has published in prestigious journals such as Science, Journal of the American Chemical Society and Analytical Biochemistry.

In The Last Decade

John V. Burba

12 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John V. Burba Canada 6 150 110 76 65 41 12 357
Burnett M. Pitt United States 8 289 1.9× 34 0.3× 252 3.3× 120 1.8× 77 1.9× 9 722
Charles F. Huebner Switzerland 15 186 1.2× 55 0.5× 397 5.2× 48 0.7× 66 1.6× 38 652
James A. Elberling United States 13 170 1.1× 22 0.2× 137 1.8× 94 1.4× 34 0.8× 25 426
George A. Boswell United States 13 132 0.9× 78 0.7× 239 3.1× 26 0.4× 32 0.8× 42 437
C. Mitoma United States 10 157 1.0× 24 0.2× 28 0.4× 44 0.7× 32 0.8× 18 423
Leo R. Swett United States 12 133 0.9× 33 0.3× 228 3.0× 20 0.3× 22 0.5× 24 385
G. H. Phillipps Germany 11 208 1.4× 28 0.3× 179 2.4× 18 0.3× 54 1.3× 32 588
He Duck Mah United States 13 199 1.3× 22 0.2× 134 1.8× 62 1.0× 63 1.5× 21 518
Thornton Sargent United States 11 91 0.6× 16 0.1× 75 1.0× 32 0.5× 39 1.0× 18 416
Michael Foreman United Kingdom 10 151 1.0× 87 0.8× 412 5.4× 15 0.2× 44 1.1× 33 742

Countries citing papers authored by John V. Burba

Since Specialization
Citations

This map shows the geographic impact of John V. Burba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John V. Burba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John V. Burba more than expected).

Fields of papers citing papers by John V. Burba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John V. Burba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John V. Burba. The network helps show where John V. Burba may publish in the future.

Co-authorship network of co-authors of John V. Burba

This figure shows the co-authorship network connecting the top 25 collaborators of John V. Burba. A scholar is included among the top collaborators of John V. Burba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John V. Burba. John V. Burba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Burba, John V., et al.. (1994). The fluorimetric determination of reducing sugars in sugar beet using benzamidine. 1 indexed citations
2.
Burba, John V.. (1983). Inhibition of hepatic azo-reductase and aromatic hydroxylase by radiopharmaceuticals containing tin. Toxicology Letters. 18(3). 269–272. 4 indexed citations
3.
Burba, John V.. (1979). Catechol O-methyltransferase activity in the human placenta and liver. Canadian Journal of Physiology and Pharmacology. 57(2). 213–216. 5 indexed citations
4.
Burba, John V.. (1968). Influence of several drugs on the in vivo and in vitro activity of mammalian hepatic azo-reductase. Canadian Journal of Biochemistry. 46(4). 367–371. 3 indexed citations
5.
Burba, John V.. (1968). Shortcomings of the quinonechloroimide colorimetric method for the determination of phenols. Analytical Biochemistry. 24(2). 344–347. 4 indexed citations
6.
Burba, John V.. (1967). THE METABOLISM AND TOXICITY OF 2,3,6-TRIAMINOPYRIDINE, A METABOLITE OF PYRIDIUM. Canadian Journal of Biochemistry. 45(6). 773–780. 3 indexed citations
7.
Burba, John V., et al.. (1965). Catechol-O-methyl transferase inhibition and potentiation of epinephrine responses by desmethylpapaverine. Biochemical Pharmacology. 14(5). 823–829. 18 indexed citations
8.
Belleau, B. & John V. Burba. (1963). Occupancy of Adrenergic Receptors and Inhibition of Catechol O-Methyl Transferase by Tropolones1,2. Journal of Medicinal Chemistry. 6(6). 755–759. 67 indexed citations
9.
Belleau, B. & John V. Burba. (1961). Tropolones: a unique class of potent non-competitive inhibitors of S-adenosylmethionine-cathechol methyltransferase. Biochimica et Biophysica Acta. 54(1). 195–196. 41 indexed citations
10.
Belleau, B., et al.. (1961). Effect of Deuterium Substitution in Sympathomimetic Amines on Adrenergic Responses. Science. 133(3446). 102–104. 114 indexed citations
11.
Belleau, B., Marie Fang, John V. Burba, & Joseph Moran. (1960). THE ABSOLUTE OPTICAL SPECIFICITY OF MONOAMINE OXIDASE. Journal of the American Chemical Society. 82(21). 5752–5754. 46 indexed citations
12.
Belleau, B. & John V. Burba. (1960). THE STEREOCHEMISTRY OF THE ENZYMIC DECARBOXYLATION OF AMINO ACIDS. Journal of the American Chemical Society. 82(21). 5751–5752. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026